BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24581197)

  • 21. HISTOPATHOLOGIC PARAMETERS OF POSITIVE LYMPH NODE PREDICTABILITY IN ENDOMETRIAL CANCER.
    Mandić A; Kokanov D; Maričić S; Ivković Kapicl T; Šolajić N
    Acta Clin Croat; 2022 Aug; 61(2):206-213. PubMed ID: 36818933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel model to estimate lymph node metastasis in endometrial cancer patients.
    Anton C; E Silva AS; Baracat EC; Dogan NU; Köhler C; Carvalho JP; di Favero GM
    Clinics (Sao Paulo); 2017 Jan; 72(1):30-35. PubMed ID: 28226030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is there an interest in para-aortic lymphadenectomy in operable endometrial cancer?].
    Bouquier J; Bricou A; Delpech Y; Tulpin L; Akerman G; Barranger E
    Bull Cancer; 2010 Feb; 97(2):199-209. PubMed ID: 19812008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
    Barlin JN; Khoury-Collado F; Kim CH; Leitao MM; Chi DS; Sonoda Y; Alektiar K; DeLair DF; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2012 Jun; 125(3):531-5. PubMed ID: 22366409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
    Larson DM; Johnson KK; Reyes CN; Broste SK
    Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
    Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph nodes: is total number or station number a better predictor of lymph node metastasis in endometrial cancer?
    Huang M; Chadha M; Musa F; Friedmann P; Kolev V; Holcomb K
    Gynecol Oncol; 2010 Nov; 119(2):295-8. PubMed ID: 20673973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of parametrial spread in endometrial carcinoma.
    Watanabe Y; Satou T; Nakai H; Etoh T; Dote K; Fujinami N; Hoshiai H
    Obstet Gynecol; 2010 Nov; 116(5):1027-34. PubMed ID: 20966685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma.
    Madom LM; Brown AK; Lui F; Moore RG; Granai CO; Disilvestro PA
    Gynecol Oncol; 2007 Oct; 107(1):75-8. PubMed ID: 17629550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodal immune reactivity in FIGO (International Federation of Gyn-Ob) Stage I endometrial carcinoma: relationship with myometrial invasion.
    Garzetti GG; Ciavattini A; Goteri G; Romanini C
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):723-8. PubMed ID: 7572108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
    Abu-Rustum NR; Gomez JD; Alektiar KM; Soslow RA; Hensley ML; Leitao MM; Gardner GJ; Sonoda Y; Chi DS; Barakat RR
    Gynecol Oncol; 2009 Nov; 115(2):236-8. PubMed ID: 19666190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.
    Kumar S; Podratz KC; Bakkum-Gamez JN; Dowdy SC; Weaver AL; McGree ME; Cliby WA; Keeney GL; Thomas G; Mariani A
    Gynecol Oncol; 2014 Jan; 132(1):38-43. PubMed ID: 24120926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial carcinoma: paraaortic dissemination.
    Mariani A; Keeney GL; Aletti G; Webb MJ; Haddock MG; Podratz KC
    Gynecol Oncol; 2004 Mar; 92(3):833-8. PubMed ID: 14984949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer?
    Turan T; Hızlı D; Yılmaz SS; Gundogdu B; Boran N; Tulunay G; Ozfuttu A; Faruk Kose M
    Arch Gynecol Obstet; 2012 Apr; 285(4):1119-24. PubMed ID: 21898081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial cancer: the potential role of cervical cytology in current surgical staging.
    DuBeshter B; Deuel C; Gillis S; Glantz C; Angel C; Guzick D
    Obstet Gynecol; 2003 Mar; 101(3):445-50. PubMed ID: 12636946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
    Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
    Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
    Dogan Altunpulluk M; Kir G; Topal CS; Cetiner H; Gocmen A
    J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.